ResMed Q1 FY2025 revenue $1.22B (+11% YoY); EPS $2.11; non-GAAP EPS $2.20; dividend $0.53

RESMED INC

2025-Q1 EPS reported $2.11 revenue$1,224,509,000

Revenue $1,224.5M, up 11% YoY (11% constant currency), driven by sleep device and mask demand.
GAAP diluted EPS $2.11; non-GAAP diluted EPS $2.20, up 34% YoY; operating profit up 34%.
Gross margin improved to 58.6% (non-GAAP 59.2%), up 420 bps YoY on manufacturing efficiencies.
Operating cash flow $326M; paid $78M dividends and repurchased $50M shares.
Board declared quarterly dividend of $0.53 per share, record date Nov 7, payable Dec 12.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.